Go To Global Site
Welcome to UCB in the United States
crop_MG_5680_cropped

Jan

12

Case Study: The Right Patients at the Right Time

Following a recent review of Tussionex® (hydrocodone polistirex and chlorpheniramine polistirex) – a cough syrup containing hydrocodone and chlorpheniramine– we determined the benefit-risk balance for the use of Tussionex® to treat cough associated with cold or allergy in children was no longer favorable. Because of this, UCB proactively approached the U.S. Food and Drug Administration (FDA) to request that Tussionex® be limited to use in adults.